Oragenics Inc (NYSEAMERICAN: OGEN) is an interesting one this morning, and for good reason. The stock is running for the top with no news released. That doesn’t mean that there’s not a reason for the gains though. The truth of the matter is that we believe that we found the trigger for the short squeeze, and this thing may run far further. Today, we’ll talk about:
- What triggered the squeeze;
- what we’re seeing from OGEN stock; and
- what we’ll be watching for ahead.
Here’s What Triggered The OGEN Short Squeeze
As mentioned above, Oragenics was an interesting stock to watch this morning. The stock started relatively flat before launching as we hit mid morning. However, no news has been released. Nonetheless, we believe that we’ve found the reason for the gains.
OGEN was a ticker that was featured in a press release surrounding news reports from Deloitte. According to the report, Deloitte sees potential in the company as technologies are driving less expensive, more efficient, and more accessible care delivery on a global scale. In fact, the report pointed to exponential technologies as a driving force in the opportunities in healthcare, stating, “exponentials will reshape health care by impacting areas such as synthetic biology, 3D printing and nanotechnology, and companion diagnostics amongst others.”
This Thing Will Squeeze The Shorts Out
With the positive report, investors started to pay attention to OGEN. From there, it was all about short interest, and it suggests that there’s plenty of room ahead. According to ShortSqueeze.com, the stock’s short interest is sitting at about 23.18% after an increase of 40%. With such high short interest and a report that seems to be assisting in a change in investor sentiment, we’re seeing what might become the beginning of a short squeeze. Given the incredibly high level of short interest on OGEN, I believe that there is room for this stock to run far higher should a short squeeze commence.
What We’re Seeing From The Stock
With the positive report surrounding healthcare and mentioning Oragenics, it only makes sense that excited investors are sending the stock on a run for the top. As is normally the case, our partners at Trade Ideas were the first to alert us to the gains. At the moment (11:33), OGEN is trading at $1.12 per share after a gain of $0.29 per share or 34.94% thus far today.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on OGEN. In particular, we’re interested in following the story surrounding the company’s continued work to bring its impressive portfolio of antibiotics to market. We’re also watching to see if this short squeeze breaks and pushes the value of the stock higher. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!